8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,713) Views
Editor in Chief Professor Garry Walsh
1178-203X
Acne phototherapy with a 1450-nm diode laser: an open study
Natusko Konishi, Hideki Endo, Naoki Oiso, Shigeru Kawara, Akira Kawada
Therapeutics and Clinical Risk Management 2007, 3:205-209
26 February 2007
Polypharmacy in elderly patients at discharge from the acute care hospital
Andrea Corsonello, Claudio Pedone, Francesco Corica, Raffaele Antonelli Incalzi, On behalf of the Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) investigators
Therapeutics and Clinical Risk Management 2007, 3:197-203
26 February 2007
Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)
Angelo J Cambio, Christopher P Evans
Therapeutics and Clinical Risk Management 2007, 3:181-196
26 February 2007
Hypokalemia secondary to capecitabine: a hidden toxicity?
Muhammad Wasif Saif, Mohammad Houman Fekrazad, Leslie Ledbetter, Robert B Diasio
Therapeutics and Clinical Risk Management 2007, 3:177-180
26 February 2007
What do parents want from their child's asthma treatment?
Stefan Walzer
Therapeutics and Clinical Risk Management 2007, 3:167-175
26 February 2007
Willingness-to-pay for caregivers of children with asthma or wheezing conditions
Stefan Walzer, Peter Zweifel
Therapeutics and Clinical Risk Management 2007, 3:157-165
26 February 2007
Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia
R Lozano, MG Peralta Concha, A Montealegre, L de Leon, J Ortiz Villalba, et al
Therapeutics and Clinical Risk Management 2007, 3:149-155
26 February 2007
Adalimumab in the treatment of arthritis
Philip J Mease
Therapeutics and Clinical Risk Management 2007, 3:133-148
26 February 2007
Optimal timing for antihypertensive dosing: focus on valsartan
Ramón C Hermida, Diana E Ayala, Carlos Calvo
Therapeutics and Clinical Risk Management 2007, 3:119-131
26 February 2007
Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
Peter Layer, Jutta Keller, Helena Loeffler, Andreas Kreiss
Therapeutics and Clinical Risk Management 2007, 3:107-118
26 February 2007
Etanercept in the treatment of rheumatoid arthritis
Boulos Haraoui, Vivian Bykerk
Therapeutics and Clinical Risk Management 2007, 3:99-105
26 February 2007
Comparison of echinocandin antifungals
Gregory Eschenauer, Daryl D DePestel, Peggy L Carver
Therapeutics and Clinical Risk Management 2007, 3:71-97
26 February 2007
Venlafaxine extended release (XR) in the treatment of panic disorder
Kevin Kjernisted, Diane McIntosh
Therapeutics and Clinical Risk Management 2007, 3:59-69
26 February 2007
Drug management in chronic rhinosinusitis: identification of the needs
Jean-Baptiste HPJ Watelet, Philippe H Eloy, Paul B van Cauwenberge
Therapeutics and Clinical Risk Management 2007, 3:47-57
26 February 2007
Drug reimportation practices in the United States
Monali J Bhosle, Rajesh Balkrishnan
Therapeutics and Clinical Risk Management 2007, 3:41-46
26 February 2007
Therapy of autoimmune bullous diseases
Diya F Mutasim
Therapeutics and Clinical Risk Management 2007, 3:29-40
26 February 2007
Acute postoperative pain management: focus on iontophoretic transdermal fentanyl
Consalvo Mattia, Flaminia Coluzzi
Therapeutics and Clinical Risk Management 2007, 3:19-27
26 February 2007
Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study
Gian Luigi Marseglia, Mariangela Tosca, Ignazio Cirillo, Amelia Licari, Maddalena Leone, Alessia Marseglia, Anna Maria Castellazzi, Giorgio Ciprandi
Therapeutics and Clinical Risk Management 2007, 3:13-17
26 February 2007
The use of amisulpride in the treatment of acute psychosis
Philippe Nuss, Martina Hummer, Cédric Tessier
Therapeutics and Clinical Risk Management 2007, 3:3-11
20 January 2007
Editorial ||FREE PAPER||
Garry M Walsh
Therapeutics and Clinical Risk Management 2007, 3:1-2
12 May 2007
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
